News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan Inc. (MYL) Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68


8/1/2013 6:57:33 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

PITTSBURGH, Aug. 1, 2013 /PRNewswire/ – Mylan Inc. (NYSE:MYL) today announced its financial results for the three and six months ended June 30, 2013.

Financial Highlights

•Adjusted diluted EPS of $0.68 for the three months ended June 30, 2013 compared to $0.60 for the same prior year period, an increase of 13%

•Total revenues of $1.70 billion for the three months ended June 30, 2013 compared to $1.69 billion for the same prior year period, an increase of 1%. On a constant currency basis and excluding the impact of Escitalopram in both periods, total revenues would have increased approximately 10%

Help employers find you! Check out all the jobs and post your resume.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES